Ibex Investors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Ibex Investors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,969	Closed	-$245K	–	112
2019 Q2	$245K	Buy	+5,969	New	+$168K	0.02%	50

Other funds holding AXNX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ibex Investors's AXNX Position: Q3 2019 in Review

Ibex Investors sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2019, closing a stake of 5,969 shares — an estimated $245K sold.

Ibex Investors first reported a position in AXNX in Q2 2019 and held it in 1 quarter. The position peaked at $245K in Q2 2019. 81 funds tracked by Wall St. Rank hold AXNX as of Q3 2019.

Ibex Investors reported no remaining Axonics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Ibex Investors sold 5,969 Axonics, Inc. Common Stock shares in Q3 2019, an estimated $245K.
Ibex Investors first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Ibex Investors's Axonics, Inc. Common Stock position peaked at $245K in Q2 2019.
81 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2019.

Based on Ibex Investors's 13F filing for Q3 2019, filed 1 Nov 2019.